Trade Gilead ^GILD

Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells $228,375.00 in Stock

Occidental Asset Management LLC Acquires 3,980 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) CFO Andrew D. Dickinson Sells 2,500 Shares of Stock

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Ritholtz Wealth Management

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Position Trimmed by Sicart Associates LLC

Gateway Investment Advisers LLC Trims Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences - January 17, 2025 - Zacks.com

Is Gilead Sciences (GILD) Among the Best NASDAQ Dividend Stocks to Buy?

Rovin Capital UT ADV Trims Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences CFO sells shares worth $228,375 By Investing.com

USA Financial Formulas Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Assenagon Asset Management S.A. Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others

Gilead, US end court battle over HIV PrEP patents | BioWorld

D Andrew Dickinson - Insider Monkey

Gilead Sciences Inc. (GILD) - Insider Monkey

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now? - January 16, 2025 - Zacks.com

Allen Mooney & Barnes Investment Advisors LLC Sells 2,205 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, US government settle patent case over HIV prevention drugs By Reuters

Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing - January 15, 2025 - Zacks.com

Global Financial Private Client LLC Boosts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Wright Investors Service Inc. Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

AdvisorNet Financial Inc Sells 336 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

LEO Pharma and Gilead Will Develop STAT6 Program for AD and Other Inflammatory Diseases

Capital Investment Advisors LLC Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

TT International Asset Management LTD Reduces Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead and Leo Pharma partner on oral STAT6 program | BioWorld

Other news to note for Jan. 13, 2025 | BioWorld

Gilead, Leo Pharma join in $1.7B deal for STAT6 program | BioWorld

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 ...

Gilead Sciences Inc (GILD) Partners with LEO Pharma to Advance STAT6 Programs for Inflammatory ...

Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD) | Markets Insider

Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters

Gilead, LEO Pharma Enter Strategic Partnership To Accelerate Development Of Oral STAT6 Program | Markets Insider

Morgan Stanley Upgrades Gilead Sciences (NASDAQ:GILD) to "Overweight"

Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com

Morgan Stanley lifts Gilead stock to Overweight on Lenacapavir potential By Investing.com

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Analysts

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by International Assets Investment Management LLC

Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know - January 9, 2025 - Zacks.com

Worth Asset Management LLC Has $828,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors | Morningstar

Nordea Investment Management AB Purchases 45,507 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities | Morningstar

Range Financial Group LLC Acquires 7,868 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Spartan Planning & Wealth Management Purchases New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

RBC keeps Gilead stock at Sector Perform, citing solid HIV foundation By Investing.com

Gilead backs proposed Poolbeg Pharma's proposed tie-up with HOOKIPA By Proactive Investors

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Fortem Financial Group LLC

Oliver Luxxe Assets LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Fortem Financial Group LLC

Pensionfund Sabic Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD): A Bull Case Theory

Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors - January 3, 2025 - Zacks.com

Revolutionizing pharma and medical device supply chains with interoperability

Short Interest in Gilead Sciences, Inc. (NASDAQ:GILD) Drops By 6.1%

HIV care | Lenacapavir was the breakthrough drug in 2024

Is Gilead Sciences, Inc. (GILD) the Best Dividend Stock of 2024?

Gilead Sciences (NASDAQ:GILD) Share Price Crosses Above 200 Day Moving Average - Time to Sell?

Rep. Marjorie Taylor Greene Buys Gilead Sciences, Inc. (NASDAQ:GILD) Shares

Is Gilead Sciences, Inc. (GILD) the Best Pharma Dividend Stock to Buy In 2024?

13 Best Pharma Dividend Stocks To Buy In 2024

Jim Cramer on Gilead Sciences, Inc. (GILD): 'I Don't Think The Business Is Worth As Much As The Stock Is Selling'

Assembly Biosciences reports positive phase 1b HBV drug results By Investing.com

In 2024, pandemic breakthroughs were for better and for worse | BioWorld

Gilead Sciences, Inc. - Insider Monkey

Gilead Sciences invests $20.1 million in Assembly Biosciences By Investing.com

Gilead Sciences (GILD) Made Big Announcements in Q3

Gilead Sciences, Inc. (NASDAQ:GILD) Position Raised by Principal Financial Group Inc.

Gilead Sciences Inc (GILD) to Present at J.P. Morgan Healthcare Conference

Gilead Sciences to Present at Upcoming Investor Conference By Investing.com

Company Website: https://www.gilead.com/ FOSTER CITY, Cali

Gilead Sciences to Present at Upcoming Investor Conference | Morningstar

Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? - December 20, 2024 - Zacks.com

Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year? - December 20, 2024 - Zacks.com

Sacituzumab Govitecan Does Not Significantly Improve OS in Pretreated Urothelial Carcinoma

Assembly Bio Receives Total $30.1 Mln As Equity Investment, Funding From Gilead, Stock Up

Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding | Morningstar

Gilead Sciences acquires $1.83 million in Xilio Therapeutics stock By Investing.com

Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs | The Manila Times

Xilio Therapeutics Enters into Additional Private Placement with Gilead; Issues Securities at $25 Million Aggregate Investment

Announces preliminary Phase 1 data for XTX301, a tumor-activ

Forex Prop Trading Updates and Income Levels' Impact on Forex

Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK

S&P 500 and Nasdaq 100 Update: Strong Earnings Drive Market Gains

Oil price today: Oil Prices Climb Amid Supply Fears

Forex market update: GBP/USD, USD/JPY Forecast

Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil